(NYSE: BLCO) Bausch & Lomb's forecast annual revenue growth rate of 5.46% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 11.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.84%.
Bausch & Lomb's revenue in 2025 is $4,684,000,000.On average, 7 Wall Street analysts forecast BLCO's revenue for 2025 to be $1,778,917,482,081, with the lowest BLCO revenue forecast at $1,741,697,618,443, and the highest BLCO revenue forecast at $1,822,448,829,375. On average, 5 Wall Street analysts forecast BLCO's revenue for 2026 to be $1,872,978,380,174, with the lowest BLCO revenue forecast at $1,807,411,425,508, and the highest BLCO revenue forecast at $1,939,719,449,700.
In 2027, BLCO is forecast to generate $1,917,885,280,150 in revenue, with the lowest revenue forecast at $1,868,582,316,650 and the highest revenue forecast at $1,967,188,243,650.